# Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder

> **NCT00294346** · PHASE2 · COMPLETED · sponsor: **Avera Pharmaceuticals** · enrollment: 180 (—)

## Conditions studied

- Social Phobia

## Interventions

- **DRUG:** AV608

## Key facts

- **NCT ID:** NCT00294346
- **Lead sponsor:** Avera Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 180 (—)
- **Last updated:** 2008-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00294346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00294346, "Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00294346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*